2.2.0.25truefalse0605 - Disclosure - Other Income (Details)truefalseIn Millionsfalse1falsefalseUSDfalsefalse1/1/2010 - 12/31/2010 USD ($) USD ($) / shares $Jan-01-2010_Dec-31-2010http://www.sec.gov/CIK0000884629duration2010-01-01T00:00:002010-12-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDEPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2falsefalseUSDfalsefalse1/1/2009 - 12/31/2009 USD ($) USD ($) / shares $TwelveMonthsEnded_31Dec2009http://www.sec.gov/CIK0000884629duration2009-01-01T00:00:002009-12-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDEPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$3falsefalseUSDfalsefalse1/1/2008 - 12/31/2008 USD ($) USD ($) / shares $TwelveMonthsEnded_31Dec2008http://www.sec.gov/CIK0000884629duration2008-01-01T00:00:002008-12-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDEPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$4falsefalseUSDtruefalse{us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis} : Scinopharm [Member] 1/1/2010 - 3/31/2010 USD ($) $ThreeMonthsEnded_31Mar2010_Scinopharm_Memberhttp://www.sec.gov/CIK0000884629duration2010-01-01T00:00:002010-03-31T00:00:00falsefalseScinopharm [Member]us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisxbrldihttp://xbrl.org/2006/xbrldiwpi_ScinopharmMemberus-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2true0wpi_OtherIncomeTextualsAbstractwpifalsenadurationOther income.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:stringItemTypestringOther income.falsefalseOther Income (Textuals) [Abstract]3false0us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestmentsus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse9540000095.4falsetruefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3truefalsefalse82000008.2falsetruefalsefalsefalse4truefalsefalse9400000094.0falsetruefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 18 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 15, 16 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 31 falsefalseNet proceeds sale of common shares4true0us-gaap_NonoperatingIncomeExpenseAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseComponent of other income5false0us-gaap_GainLossOnInvestmentsus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse2560000025.6falsefalsefalsefalsefalse2truefalsefalse-1100000-1.1falsefalsefalsefalsefalse3truefalsefalse96000009.6falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThis item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain or loss of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain or loss which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains or losses realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments of the subject investments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 7 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 115 -Paragraph 13, 22 falsefalseGain (loss) on sale of securities6false0us-gaap_IncomeLossFromEquityMethodInvestmentsus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse16000001.6falsefalsefalsefalsefalse2truefalsefalse1080000010.8falsefalsefalsefalsefalse3truefalsefalse1060000010.6falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThis item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 18 -Paragraph 19 -Subparagraph c Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 11 -Article 7 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 95 -Paragraph 28 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 18 -Paragraph 6 -Subparagraph b falsefalseEarnings on equity method investments7false0us-gaap_GainsLossesOnExtinguishmentOfDebtus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse-500000-0.5falsefalsefalsefalsefalse2truefalsefalse-2000000-2.0falsefalsefalsefalsefalse3truefalsefalse-1100000-1.1falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryAmount represents the difference between the fair value of the payments made and the carrying amount of the debt at the time of its extinguishment.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 26 -Paragraph 20, 21 falsefalseLoss on early extinguishment of debt8false0wpi_OtherIncomeswpifalsecreditdurationOther incomes.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse10000001.0falsefalsefalsefalsefalse2truefalsefalse2000000.2falsefalsefalsefalsefalse3truefalsefalse2000000.2falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryOther incomes.No authoritative reference available.truefalseOther incomes9false0us-gaap_OtherNonoperatingIncomeExpenseus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse2770000027.7falsetruefalsefalsefalse2truefalsefalse79000007.9falsetruefalsefalsefalse3truefalsefalse1930000019.3falsetruefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe net amount of other nonoperating income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 truefalseOther income48Other Income (Details) (USD $)HundredThousandsUnKnownUnKnownUnKnownfalsetrue